{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:03:53Z","timestamp":1793037833413,"version":"4.5.0"},"reference-count":14,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamadermatol.2021.4084","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T18:34:55Z","timestamp":1636569295000},"page":"1477","source":"Crossref","is-referenced-by-count":24,"title":["Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis"],"prefix":"10.1001","volume":"157","author":[{"given":"Michael J.","family":"Murphy","sequence":"first","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Gruenstein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Levitt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"King","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Damsky","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut"},{"name":"Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2 Pt 2","key":"dbr210019r1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0190-9622(95)91435-8","article-title":"Persistent erythema multiforme: report of two new cases and review of literature.","volume":"33","author":"Drago","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"dbr210019r2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-3083.2001.00185.x","article-title":"Persistent erythema multiforme: a report of three cases.","volume":"15","author":"Pavlovic","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"dbr210019r3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007.","volume":"62","author":"Wetter","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"dbr210019r4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","article-title":"Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions.","volume":"113","author":"Kokuba","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"4","key":"dbr210019r5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bjd.2006.155.issue-4","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"155","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"issue":"5","key":"dbr210019r6","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.18256","article-title":"Image gallery: tofacitinib for treatment of herpes-associated erythema multiforme.","volume":"181","author":"von Csiky-Sessoms","year":"2019","journal-title":"Br J Dermatol"},{"issue":"6","key":"dbr210019r7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jdcr.2016.10.009","article-title":"Idiopathic erythema multiforme: Evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib.","volume":"2","author":"Damsky","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"2","key":"dbr210019r8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/acr2.v2.2","article-title":"Treatment of multiorgan sarcoidosis with tofacitinib.","volume":"2","author":"Damsky","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"dbr210019r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xjidi.2021.100021","article-title":"Cytokine RNA in situ hybridization permits individualized molecular phenotyping in biopsies of psoriasis and atopic dermatitis.","volume":"1","author":"Wang","year":"2021","journal-title":"JID Innov"},{"issue":"3","key":"dbr210019r10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jaci.2020.10.022","article-title":"The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases.","volume":"147","author":"Damsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"6-7","key":"dbr210019r11","first-page":"375","article-title":"Treatment by thalidomide of chronic multiforme erythema: its recurrent and continuous variants: a retrospective study of 26 patients.","volume":"123","author":"Cherouati","year":"1996","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"dbr210019r12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdcr.2016.11.009","article-title":"Treatment of recurrent erythema multiforme with adalimumab as monotherapy.","volume":"3","author":"Baillis","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"7","key":"dbr210019r13","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.4049\/jimmunol.181.7.4461","article-title":"IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages.","volume":"181","author":"Vila-del Sol","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"dbr210019r14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm0297-189","article-title":"Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis.","volume":"3","author":"McInnes","year":"1997","journal-title":"Nat Med"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2785841\/jamadermatology_murphy_2021_br_210019_1639533872.79203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T21:33:52Z","timestamp":1673732032000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2785841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.4084","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}